Infinium Global Research Biosimilar Monoclonal Antibodies Market | Page 5

5.2 Oncology
5.3 Chronic and Autoimmune Diseases
5.4 Growth Hormone Deficiency
5.5 Infectious Diseases
5.6 Others
6. Global Biosimilar Monoclonal Antibodies Market, by Region, (USD Million) 2015 - 2023
6.1 Introduction
6.2 North America
6.2.1 North America Biosimilar Monoclonal Antibodies Market, by Drug Class (USD Million)
6.2.2 North America Biosimilar Monoclonal Antibodies Market, by Application (USD Million)
6.3 Europe
6.3.1 Europe Biosimilar Monoclonal Antibodies Market, by Drug Class (USD Million)
6.3.2 Europe Biosimilar Monoclonal Antibodies Market, by Application (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Biosimilar Monoclonal Antibodies Market, by Drug Class (USD Million)
6.4.2 Asia Pacific Biosimilar Monoclonal Antibodies Market, by Application (USD Million)
6.5 Latin America
6.5.1 Latin America Biosimilar Monoclonal Antibodies Market, by Drug Class (USD Million)
6.5.2 Latin America Biosimilar Monoclonal Antibodies Market, by Application (USD Million)
6.6 Rest of the World
6.6.1 RoW Biosimilar Monoclonal Antibodies Market, by Drug Class (USD Million)
6.6.2 RoW Biosimilar Monoclonal Antibodies Market, by Application (USD Million)
7. Leading Companies
7.1 Company Profiles
7.1.1 Pfizer, Inc.
7.1.2 Novartis AG
7.1.3 Reliance Life Sciences
7.1.4 Allergan plc
7.1.5 Coherus BioSciences, Inc.
7.1.6 Biocon
Infinium Global Research